ADIL — Adial Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $7.83m
- $5.00m
Annual cashflow statement for Adial Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.59 | -10.9 | -19.4 | -12.7 | -7 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.04 | 2.01 | 6.09 | 2.9 | 0.989 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.208 | 1.25 | 1.47 | -1.37 | -0.794 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -6.34 | -7.63 | -11.9 | -11.2 | -6.81 |
| Capital Expenditures | — | — | -0.065 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.35 | 0.031 | 0 | 1.5 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.35 | -0.034 | 0 | 1.5 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.25 | 5.61 | 13.6 | 9.13 | 4.13 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.91 | -2.38 | 1.66 | -2.06 | -1.17 |